Genming Shi
Impact in
- Dermatology top 5%
- Dermatology and Skin Diseases
- Medicine and Dermatology Studies History
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Dermatology and Skin Diseases 2
- Contact Dermatitis and Allergies 1
-
- Urticaria and Related Conditions 2
- Co-authors
- Maud N. Vissers (1 shared paper)Anouk van der Graaf (1 shared paper)Mieke D. Trip (1 shared paper)Claude Gagné (1 shared paper)John J.P. Kastelein (1 shared paper)Hans J. Avis (1 shared paper)Enrico P. Veltri (1 shared paper)Elizabeth Laws (2 shared papers)
- Journals
- British Journal of Dermatology (1 paper)The Lancet Respiratory Medicine (1 paper)Nature Medicine (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Genming Shi
4 papers receiving 459 citations
Genming Shi's Hit Papers
Peers
Comparison fields: 5 of 59
- Dermatology 136
- Infectious Diseases 138
- Neurology 75
- Rheumatology 56
- Endocrinology, Diabetes and Metabolism 46
Countries citing papers authored by Genming Shi
This map shows the geographic impact of Genming Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genming Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genming Shi more than expected).
Fields of papers citing papers by Genming Shi
This network shows the impact of papers produced by Genming Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genming Shi. The network helps show where Genming Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Genming Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 195 | |
| 2 | Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials Hit paper breakdown → | 2023 | 159 |
| 3 | 2008 | 111 | |
| 4 | 2023 | 3 |
About Genming Shi
Genming Shi is a scholar working on Dermatology, Rheumatology, Pathology and Forensic Medicine, Infectious Diseases and Surgery, having authored 4 papers that have together received 468 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (2 papers), Urticaria and Related Conditions (2 papers), COVID-19 Clinical Research Studies (1 paper), Contact Dermatitis and Allergies (1 paper), Lipoproteins and Cardiovascular Health (1 paper) and Autoimmune Bullous Skin Diseases (1 paper). The work is most often cited by research in Dermatology (136 citations), Infectious Diseases (138 citations), Neurology (75 citations), Rheumatology (56 citations) and Endocrinology, Diabetes and Metabolism (46 citations). Genming Shi has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Maud N. Vissers, Anouk van der Graaf, Mieke D. Trip, Claude Gagné, John J.P. Kastelein, Hans J. Avis, Enrico P. Veltri, Elizabeth Laws, Sonja Ständer and Gil Yosipovitch. Their work appears in journals such as British Journal of Dermatology, The Lancet Respiratory Medicine, Nature Medicine and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.